Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) had its price objective dropped by research analysts at Jefferies Group from $18.00 to $17.00 in a research report issued to clients and investors on Tuesday, StockTargetPrices.com reports. The firm currently has a “buy” rating on the stock. Jefferies Group’s price objective would suggest a potential upside of 38.32% from the […]
